{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:21:22Z","timestamp":1761060082292,"version":"3.40.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.thromres.2016.01.010","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T17:46:40Z","timestamp":1455731200000},"page":"89-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Oral anticoagulant therapy interruption in children: A single centre experience"],"prefix":"10.1016","volume":"140","author":[{"given":"Sally","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3970-8984","authenticated-orcid":false,"given":"Paul","family":"Monagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Newall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2 Suppl","key":"10.1016\/j.thromres.2016.01.010_bb0005","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"issue":"4\u20135","key":"10.1016\/j.thromres.2016.01.010_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.blre.2010.06.003","article-title":"Anticoagulation in neonates and children: pitfalls and dilemmas","volume":"24","author":"Monagle","year":"2010","journal-title":"Blood Rev."},{"issue":"3","key":"10.1016\/j.thromres.2016.01.010_bb0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.2010.08225.x","article-title":"Aspects of anticoagulation in children","volume":"150","author":"Payne","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.thromres.2016.01.010_bb0020","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V94.9.3007","article-title":"Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients","volume":"94","author":"Streif","year":"1999","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2016.01.010_bb0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.thromres.2012.03.028","article-title":"Anticoagulation in children","volume":"130","author":"Monagle","year":"2012","journal-title":"Thromb. Res."},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2016.01.010_bb0030","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.thromres.2016.01.010_bb0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5694\/mja12.10614","article-title":"An update of consensus guidelines for warfarin reversal","volume":"198","author":"Tran","year":"2013","journal-title":"Med. J. Aust."},{"issue":"9","key":"10.1016\/j.thromres.2016.01.010_bb0040","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2016.01.010_bb0045","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.thromres.2012.06.010","article-title":"Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience","volume":"130","author":"Moruf","year":"2012","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2016.01.010_bb0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V70.1.165.165","article-title":"Development of the human coagulation system in the full-term infant","volume":"70","author":"Andrew","year":"1987","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2016.01.010_bb0055","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood.V80.8.1998.1998","article-title":"Maturation of the hemostatic system during childhood","volume":"80","author":"Andrew","year":"1992","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2016.01.010_bb0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1160\/TH05-01-0047","article-title":"Developmental haemostasis. Impact for clinical haemostasis laboratories","volume":"95","author":"Monagle","year":"2006","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2016.01.010_bb0065","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1067\/mpd.2001.111330","article-title":"Moyamoya disease complicated with renal artery stenosis and nephrotic syndrome: reversal of nephrotic syndrome after nephrectomy","volume":"138","author":"Kuwayama","year":"2001","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.thromres.2016.01.010_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000097528","article-title":"Moyamoya disease associated with midaortic syndrome","volume":"43","author":"Korematsu","year":"2007","journal-title":"Pediatr. Neurosurg."},{"issue":"12","key":"10.1016\/j.thromres.2016.01.010_bb0075","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2016.01.010_bb0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.12659\/AJCR.890222","article-title":"Clinical and angiographic findings in Moya Moya","volume":"15","author":"Sharma","year":"2014","journal-title":"Am. J. Case Rep."},{"issue":"2 Suppl. Pediatrics","key":"10.1016\/j.thromres.2016.01.010_bb0085","first-page":"142","article-title":"Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis","volume":"100","author":"Scott","year":"2004","journal-title":"J. Neurosurg."},{"issue":"3","key":"10.1016\/j.thromres.2016.01.010_bb0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jacc.2012.08.1023","article-title":"Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2years after the Fontan procedure","volume":"61","author":"McCrindle","year":"2013","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816300123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816300123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T16:37:04Z","timestamp":1600187824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384816300123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":18,"alternative-id":["S0049384816300123"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2016.01.010","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral anticoagulant therapy interruption in children: A single centre experience","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2016.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}